ARROCase Submission Guidelines and Topics

Submission Guidelines

Residents/Fellows are encouraged to partner with attendings at ACGME accredited institutions who specialize in a given disease site to develop cases that serve to guide residents through both common and challenging clinical situations encountered within the field of radiation oncology.

We aim to build as comprehensive a database as possible. Therefore, we would like authors to send case suggestion notifications prior to submission to ascertain availability.

Cases should be as follow:

• Maximum number of slides 25.
• Outline:
  • Title slide: Case title, authors’ names and affiliations, date of submission.
  • Clinical presentation: Pertinent presenting symptoms, key radiographic images.
  • Diagnostic work-up.
  • General disease site principles.
  • General management.
  • Radiation planning: Simulation, Radiation options.
  • Treatment planning: Define GTV/CTV/PTV, normal structures, Dose, DVH.
  • High-yield facts.
  • References including potential seminal journal articles/studies.
• Ensure all protected health information (i.e., names, medical records numbers, DOB) has been removed. If photos of patients are used and are identifiable, written consent from the patient must be obtained.
• If cases contain copyrighted material (e.g., figures, tables, images), permission will need to be obtained from the publisher. If the figure or table is reproduced from scratch, written permission is not required, but the reference should be cited.
• Cases should use product names and generic names in lieu of proprietary names.
• Include references for all cited journal articles/studies on the final slide.

Cases should be submitted via email to ARRO. After a case is received, the ARRO Education Subcommittee will review it for content. Any suggested changes/revisions will be directed to the contributor prior to finalization of cases. Finalized cases will be posted on the ARRO website with contributing authors contact information.

ARROcases Topic Areas

• CNS
  • Low-grade glioma
  • High-grade glioma
    • Anaplastic astrocytoma
    • Glioblastoma multiforme
  • Brainstem glioma
  • Meningioma
  • Acoustic neuroma
  • Pituitary adenoma
• Head and Neck
  • Nasopharnyx
  • Oral Cavity
  • Oropharynx
  • Larynx
  • Hypopharynx
  • Major salivary gland
  • Nasal cavity
  • Thyroid cancer
  • Head and neck unknown primary
• Thoracic
  • Small cell
  • Non-small cell
    • Early stage
    • Locally advanced
  • Thymoma
  • Mesothelioma
• Breast
  • DCIS
  • Early stage, intact breast
  • Locally advanced, chest wall
  • Inflammatory breast cancer
• Gastrointestinal
  • Esophageal
  • Gastric
  • Pancreatic
  • Biliary
  • Rectal
  • Anal
• Genitourinary
  • Prostate intact
    • Low risk
    • Intermediate risk
    • High risk
  • Prostate post-prostatectomy
    • Adjuvant
    • Salvage
  • Bladder
  • Testicular
  • Penile
• Gynecologic
  • Endometrial
  • Cervix
  • Vaginal
  • Vulvar
• Lymphomas and Hematologic
  • Hodgkins lymphoma
  • Non-Hodgkins lymphoma
  • CNS lymphoma
  • Multiple myeloma
  • Mycosis fungoides
• Pediatric
  • Wilm’s tumor
  • Retinoblastoma
  • Neuroblastoma
  • Pediatric lymphomas
  • Rhabdomyosarcoma
  • Craniopharyngioma
  • Medulloblastoma
  • Ependymoma
• Sarcomas/Misc.
  • Soft tissue sarcomas
  • Pediatric sarcomas
  • Malignant melanoma
• Benign
  • Heterotopic ossification
  • Keloid
  • Kaposi sarcoma
  • Gynecomastia
• Palliative
  • Brain metastases
    • Whole brain
    • SRS
  • Bone metastases
  • Gynecologic bleeding
  • Spinal cord compression